Peters, K., Affronti, M. L., Woodring, S., Lipp, E., Healy, P., McSherry, F., … Friedman, H. (2015). Placebo-controlled, double-blind, randomized pilot study to evaluate the effects of low-dose naltrexone on quality of life and fatigue in newly diagnosed high-grade glioma. In Neurology (Vol. 84, pp. P4–P4). Washington, DC.

Peters, Katherine, Mary Lou Affronti, Sarah Woodring, Eric Lipp, Patrick Healy, Frances McSherry, James Herndon, et al. “Placebo-controlled, double-blind, randomized pilot study to evaluate the effects of low-dose naltrexone on quality of life and fatigue in newly diagnosed high-grade glioma.” In Neurology, 84:P4–P4, 2015.

Peters K, Affronti ML, Woodring S, Lipp E, Healy P, McSherry F, et al. Placebo-controlled, double-blind, randomized pilot study to evaluate the effects of low-dose naltrexone on quality of life and fatigue in newly diagnosed high-grade glioma. In: Neurology. 2015. p. P4–P4.

Peters, Katherine, et al. “Placebo-controlled, double-blind, randomized pilot study to evaluate the effects of low-dose naltrexone on quality of life and fatigue in newly diagnosed high-grade glioma.” Neurology, vol. 84, no. 14s, 2015, pp. P4–P4.

Peters K, Affronti ML, Woodring S, Lipp E, Healy P, McSherry F, Herndon J, Flahiff C, Miller E, Freeman M, Minchew J, Zalutsky B, Taylor B, Boulton S, Randazzo D, Desjardins A, Vlahovic G, Bigner D, Friedman H. Placebo-controlled, double-blind, randomized pilot study to evaluate the effects of low-dose naltrexone on quality of life and fatigue in newly diagnosed high-grade glioma. Neurology. 2015. p. P4–P4.